Equity Details
Price & Market Data
Price: $0.621
Daily Change: -$0.0173 / 2.78%
Daily Range: $0.588 - $0.65
Market Cap: $16,828,424
Daily Volume: 708,091
Performance Metrics
1 Week: -10.77%
1 Month: -24.79%
3 Months: -24.46%
6 Months: -50.96%
1 Year: -21.47%
YTD: -21.11%
About Citius Pharmaceuticals, Inc. (CTXR)
A concise report on Citius Pharmaceuticals, Inc. (CTXR). Price: 0.621, daily change: -$0.0173 / 2.78%. Market cap: 16,828,424. YTD performance and 1-month returns.
Company Details
Employees: 23
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.